To investigate the relationship between metabolic parameters of 18F-fluorodeoxyglucose (
18
F-FDG) PET/CT of bone metastases and serum markers in the patients with prostate cancer.
Methods:
Retrospective analysis was carried out in 48 patients with prostate cancer hospitalized in Shandong Cancer Hospital Affiliated to Shandong University from Jan. 2012 to Dec. 2014. The patients underwent
18
F-FDG PET/CT examination within a week after admission. The relationship between metabolic parameters of
18
F-FDG PET/CT such as number of metastatic bone lesion
maximum standardized uptake value (SUV
max
)
mean SUV (SUV
mean
)
metabolic tumor volume (MTV) and total lesion glycolysis (TLG) and serum tumor markers in the corresponding period were analyzed.
Results:
The number of metastatic bone lesion of 8 was set as the best cutoff point to predict the overall survival (OS) of the patients with prostate cancer
who were divided into no bone metastasis group
limited bone metastasis group (1-8 lesions) and diffuse bone metastasis group (more than 8 lesions). There was significant difference in the level of alkaline phosphatase (ALP) between limited bone metastasis group and no bone metastasis group. The levels of total prostate-specific antigen (tPSA)
free frostatespecific awtigen (fPSA) and ALP were statistically significant among three groups. The positively correlated relationship was shown between the number of metastatic bone lesion and the corresponding levels of tPSA
fPSA and ALP (
r
=0.604
P
=0.02;
r
=0.531
P
=0.03;
r
=0.478
P
=0.018). There was no correlation between SUV
max
value of metastatic bone lesion and the level of ALP
between SUV
mean
value of metastatic bone lesion and the levels of ALP and fPSA. The rest para
meters and biomarkers were correlated.
Conclusion:
The number of metastatic bone lesion of 8 is the optimal cutoff point to predict the OS of patients with prostate cancer. tPSA
fPSA and ALP can be used as clinical blood biochemical indicators for diffuse bone metastasis in the patients with prostate cancer.
MTV
and
TLG
combined with tPSA
fPSA and ALP are better than SUV
max
and SUV
mean
in evaluation of bone metastases.
TLG
could be used to evaluate the prognosis of prostate cancer.
A comparative study of 68Ga-TBM-001 PET/CT and 99mTc-MDP bone scintigraphy in the diagnosis of bone metastases of prostate cancer
Value of contrast-enhanced transrectal ultrasound in evaluating the response of prostate cancer to neoadjuvant hormonal therapy
The value of quantitative parameters of amide proton transfer imaging in predicting bone metastasis of prostate
Diagnostic value of PSAD, TRTE combined with mpMRI for prostate cancer in grey area of PSA
Intratumoural and peritumoural mpMRI-based Delta-radiomics model for the prediction of the response to androgen deprivation therapy in prostate cancerLI Rong1, WANG Ting1, LÜ Hong2, LIU Xiaohang1, ZHOU Liangping1, GU Yajia1, ZHOU Bingni1
Related Author
Dan SU
Taoming DU
Yue CHEN
ZHAO Yunxin
ZHANG Bei
WANG Xiaolian
ZHOU Shihui
CAI Qiuqiong
Related Institution
Department of Radiology, Chengdu Seventh People’s Hospital, Affilitated Cancer Hospital of Chengdu Medical College
Department of Nuclear Medicine, Chengdu Seventh People’s Hospital, Affilitated Cancer Hospital of Chengdu Medical College
Department of Nuclear Medicine, Affilitated Hospital of Southwest Medical University
Major of Biology and Medicine, Bioengineering College of Chongqing University
Department of Radiology, Chongqing University Cancer Hospital